Loading clinical trials...
Loading clinical trials...
The CandLE study with at maximum daily dose of 32 mg candesartan or 16/12.5 mg candesartan/hydrochlorothiazide has the objective to evaluate under naturalistic conditions, i.e. under routine medical c...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT05593055 · Hypertension, Left Ventricular Hypertrophy
NCT06823947 · Healthy Volunteers Essential Hypertension
NCT03549559 · Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, and more
NCT07263204 · Hypertrophic Cardiomyopathy (HCM), Left Ventricular Hypertrophy
NCT07051811 · Essential Hypertension
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions